EssilorLuxottica (OTCMKTS:ESLOY) Hits New 1-Year Low – Here’s Why

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY)’s stock price reached a new 52-week low on Tuesday . The company traded as low as $116.28 and last traded at $116.7050, with a volume of 32733 shares. The stock had previously closed at $117.72.

Analysts Set New Price Targets

ESLOY has been the subject of a number of analyst reports. The Goldman Sachs Group restated a “buy” rating on shares of EssilorLuxottica in a research note on Friday, December 5th. Kepler Capital Markets raised shares of EssilorLuxottica from a “hold” rating to a “buy” rating in a report on Thursday, January 15th. HSBC upgraded EssilorLuxottica from a “hold” rating to a “buy” rating in a report on Wednesday, January 14th. UBS Group upgraded EssilorLuxottica from a “hold” rating to a “strong-buy” rating in a research note on Thursday, November 27th. Finally, Citigroup reaffirmed a “buy” rating on shares of EssilorLuxottica in a research report on Thursday, December 11th. Two equities research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Buy”.

EssilorLuxottica Trading Down 0.1%

The stock’s 50 day simple moving average is $144.11 and its 200-day simple moving average is $159.86. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.70 and a current ratio of 0.99.

About EssilorLuxottica

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.